期刊文献+

乙二醛酶-Ⅰ单核苷酸多态性对糖尿病周围大血管并发症的影响 被引量:1

The single nucleotide polymorphism of glyoxalase-Ⅰ gene C329A associated with diabetic peripheral macrovascular complications
原文传递
导出
摘要 目的 研究乙二醛酶 Ⅰ基因单核苷酸多态性与糖尿病周围大血管病并发症的相关性。方法 收集糖尿病有、无周围大血管并发症DNA样本各 3 6例及 46例 ,正常对照 49例。采用聚合酶链反应结合测序的方法。结果 检出C3 2 9A和A3 69T两个多态位点。糖尿病有周围大血管病变组C3 2 9A位点AA型基因型频率 72 .2 %明显高于糖尿病无周围大血管并发症组的 5 0 .0 % (P <0 .0 5 )和正常人组的 49.0 % (P <0 .0 5 ) ,通过 χ2 检验 ,此位点为AA型患周围血管病变的危险性增加(OR =2 .6,95 %可信限为 1.0 2 5~ 6.5 93 ,P <0 .0 5 )。糖尿病有、无周围大血管病变组及正常人组的A3 69T位点AA基因型频率分别为 5 5 .6%、60 .9%及 61.2 % ,三组间无显著差异。结论 乙二醛酶 IC3 2 9A位点AA基因型与糖尿病周围大血管并发症有相关性。 Objectives To investigate the association of single nucleotide polymorphisms (SNPs) of glyoxalase-Ⅰ gene with diabetic peripheral macrovascular complications.Methods Total 36 diabetic patients with,46 without diabetic peripheral macrovascular complications and 49 normal controls were recruited.SNPs of glyoxalase-Ⅰ gene were genotyped by polymerase chain reaction (PCR) and subsequent direct sequencing.Results Two SNPs were found in the gene,A C/A at nucleotide (nt) position 329 and another A/T at nt position 369.The frequency of genotype AA of glyoxalase-Ⅰ gene at 329 were significantly higher in patients with peripheral macrovascular complications (72.2%) than that in patients without the complications (50.0%,P<0.05) and that in normal controls (49%,P<0.05),Chi-square test showed that 329AA in type 2 diabetic patients associated with a 2.6-fold increase in risk of diabetic peripheral macrovascular complications (95%CI: 1.025 to 6.593,P<0.005).No significant difference of 369AA of glyoxalase-Ⅰ gene were seen among diabetic patients with (55.6%),without (60.9%) peripheral macrovascular complications and controls (61.2%)(P>0.05).Conclusion Genotype 329AA of glyoxalase-Ⅰ gene were associated with diabetes peripheral macrovascular complications.
出处 《临床内科杂志》 CAS 北大核心 2004年第6期380-382,共3页 Journal of Clinical Internal Medicine
关键词 乙二醛酶-Ⅰ 单核苷酸多态性 糖尿病周围大血管并发症 Glyoxalase-Ⅰ Single nucleotide polymorphisms Diabetic peripheral macrovascular complications
  • 相关文献

参考文献12

  • 1Singh R,Barden A,Mori T,et al.Advanced glycation end-products:a review.Diabetologia,2001,44(2):129-146.
  • 2Thornalley PJ,Langborg A,Minhas HS,et al.Formation of glyoxal,methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.Biochem J,1999,344(1):109-116.
  • 3Thornalley PJ.The glyoxalase system in health and disease.Mol Aspects of Med,1993,14(4):287-371.
  • 4Shinohara M,Thornalley PJ,Giardino I,et al.Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis.J Clin Invest,1998,101(5):1142-1147.
  • 5Hou SM,Nori P,Fang JL,et al.Methylglyoxal induces hprt mutation and DNA adducts in human T-lympHocytes in vitro Environ.Mol Mutagen,1995,26(4):286-291.
  • 6Westwood ME ,Thornalley PJ.Molecular characteristics of methylglyoxalmodified bovine and human serum albumins.Comparison with glucosederived advanced glycation endproduct-modified serum albumins.J Prot Chem,1995,14(5):359 -372.
  • 7Allen RE,Lo TW,Thomalley PJ.A samplified method for the purrfication of human red blood cell glyoxalase I.Characsteristics immunoblotting and inhibitor studies.J Protein Chem,1993,12(2):111-119.
  • 8Thornalley PJ.The glyoxalase system:new developments towards functional characterization of a metabolic pathway fundamental to biological life.Biochem J,1990,269(1):1-11.
  • 9Richter U,Krauss M.Active site structure and mechanism of human glyoxalase I-an ab initic theoretical study.J Am Chem Soc,2001,123(29):6973-6982.
  • 10Miyata T,Strihou C ,Imasawa T,et al.Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products is a hemodialysis patient.Kidney International,2001,60 (6):2351-2355.

同被引文献13

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33004
  • 2张冰,程罡,王莉莉,李松.晚期糖基化终产物靶向治疗药物与糖尿病血管内皮功能紊乱[J].中国药理学通报,2007,23(5):565-567. 被引量:10
  • 3Kim BJ,Kim JS. Ischemic stroke subtype classification: an asianviewpoint [ J]. J Stroke, 2014, 16( 1 ) : 8-17.
  • 4Kislinger T, Tanji N, Wendt T,et al. Receptor for advancedglycation end products mediates inflammation and. enhancedexpression of tissue factor in vasculature of diabetic apolipoproteinE-null mice [ J]. Arterioscler Thromb Vase Biol, 2001 , 21(6):905-910.
  • 5Kalousovd M, Zima T,Tesar V,et al. Advanced glycoxidationend products in chronic diseases-clinical chemistry and geneticbackground [ J]. Mutat Res, 2005 , 579( 1-2) : 37-46.
  • 6Forbes JM, Yee LT, Thallas V,et al. Advanced glycation endproduct interventions reduce diabetes-accelerated atherosclerosis[J]. Diabetes, 2004,53(7) ; 1813-1823.
  • 7Sidoti A, Antognelli C, Rinaldi C,et al. Glyoxalase I All IE,paraoxonase 1 Q192R and L55M polymorphisms: susceptibilityfactors of multiple sclerosis? [J]. Mult Scler, 2007, 13 (4):446453.
  • 8Peculis R, Konrade I,Skapare E, et al. Identification ofglyoxalase 1 polymorphisms associated with enzyme activity [ J ].Gene, 2013,515(1) : 140-143.
  • 9Wei W, Luo HB, Yan J, et al. Exploring of new Y-chromosomeSNP loci using Pyrosequencing and the SNaPshot methods [ J].Int J Legal Med, 2012, 126(6) : 825-833.
  • 10Schalkwijk CG, van Bezu J, van der Schors RC, et al. Heat-shock protein 27 is a major methylglyoxal-modified protein inendothelial cells [J]. FEBS Lett, 2006,580(6) : 1565-1570.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部